LYS-ARG-PRO-PRO-GLY-PHE-SER-PRO-PHE-ARG 基本信息
| 中文名称 | LYS-ARG-PRO-PRO-GLY-PHE-SER-PRO-PHE-ARG |
|---|---|
| 中文同义词 | 胰激肽;缓激肽前体肽H-LYS-ARG-PRO-PRO-GLY-PHE-SER-PRO-PHE-ARG-OH;缓激肽前体肽H;缓激肽[LYS0]BRADYKININ |
| 英文名称 | KALLIDIN |
| 英文同义词 | LYS-ARG-PRO-PRO-GLY-PHE-SER-PRO-PHE-ARG: KRPPGFSPFR;2-[[2-[[1-[2-[[2-[[2-[[1-[1-[2-(2,6-diaminohexanoylamino)-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]pyrrolidine-2-carbonyl]amino]acetyl]amino]-3-phenylpropanoyl]amino]-3-hydroxypropanoyl]pyrrolidine-2-carbonyl]amino]-3-phenylpropanoyl]amino]-5-(diaminomethylideneamino)pentanoic acid;2-[[2-[[1-[2-[[2-[[2-[[1-[1-[2-(2,6-diaminohexanoylamino)-5-guanidino-pentanoyl]pyrrolidine-2-carbonyl]pyrrolidine-2-carbonyl]amino]acetyl]amino]-3-phenyl-propanoyl]amino]-3-hydroxy-propanoyl]pyrrolidine-2-carbonyl]amino]-3-phenyl-propanoyl]amino]-5-guanidino-valeric acid;2-[[2-[[1-[2-[[2-[2-[[1-[1-[2-[2,6-bis(azanyl)hexanoylamino]-5-[bis(azanyl)methylideneamino]pentanoyl]pyrrolidin-2-yl]carbonylpyrrolidin-2-yl]carbonylamino]ethanoylamino]-3-phenyl-propanoyl]amino]-3-hydroxy-propanoyl]pyrrolidin-2-yl]carbonylamino]-3-phenyl-propanoyl]amino]-5-[bis(azanyl)methylideneamino]pentanoic acid;BRADYKININ (LYS);H-LYS-ARG-PRO-PRO-GLY-PHE-SER-PRO-PHE-ARG-OH;[LYS0] BRADYKININ;[LYS0]-BRADYKININ (KALLIDIN) |
| CAS号 | 342-10-9 |
| 分子式 | C56H85N17O12 |
| 分子量 | 1188.38 |
| EINECS号 | 206-438-0 |
| 相关类别 | 多肽;peptide |
| Mol文件 | 342-10-9.mol |
| 结构式 |  |
LYS-ARG-PRO-PRO-GLY-PHE-SER-PRO-PHE-ARG 性质
| 比旋光度 | D21 -57° (c = 1 in N acetic acid) |
|---|---|
| 储存条件 | -15°C |
| 形态 | 粉末 |
| 水溶解性 | Soluble in water at 1mg/ml |